Array BioPharma Slaps $192M Lawsuit on AstraZeneca Over Cancer Drug Royalties Post author:Sam Post published:February 1, 2018 Post category:BioPharma AstraZeneca did not immediately respond to a request for comment. Source: BioSpace You Might Also Like FDA Approval of Drug May Have Made This Bay Area Pharma a New M&A Target June 26, 2017 iCAD Wins FDA Approval for PowerLook Tomo Detection March 26, 2017 Magellan Diagnostics And Partner To Identify Lead Exposure In Giant Pandas March 16, 2017
